Study Title: A Phase 2 Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Christopher Rangel, at rangelc@musc.edu.Study Coordinator, Alec Schumpp, at schumpp@musc.edu.Trial opened at the following institutions: Medical University of South Carolina